| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0169-328X(01)00216-9 |
| P698 | PubMed publication ID | 11731015 |
| P2093 | author name string | Mitchell V | |
| Pierce A | |||
| Benaïssa M | |||
| Fillebeen C | |||
| Ruchoux MM | |||
| Vincent S | |||
| P2860 | cites work | Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte | Q24304897 |
| The etiology of Parkinson's disease with emphasis on the MPTP story | Q29036950 | ||
| Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. | Q30854285 | ||
| Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines | Q30919473 | ||
| The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease | Q33543091 | ||
| Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process | Q33649849 | ||
| Regulation of lactoferrin gene expression by estrogen and epidermal growth factor: molecular mechanism | Q33743319 | ||
| Regulatory mechanisms of cellular response to oxidative stress | Q33750101 | ||
| Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease | Q33856488 | ||
| Structure and biological actions of lactoferrin | Q33962822 | ||
| Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines | Q36034014 | ||
| Brain macrophages: questions of origin and interrelationship | Q39647584 | ||
| Lactoferrin is a lipid A-binding protein. | Q39860656 | ||
| Complete nucleotide sequence of human mammary gland lactoferrin | Q40523604 | ||
| Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. | Q40969107 | ||
| The microglial cell. A historical review | Q41144699 | ||
| Elevated circulating tumor necrosis factor levels in Alzheimer's disease | Q41145103 | ||
| Oxidative stress and the pathogenesis of Parkinson's disease | Q41262986 | ||
| Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen | Q41313592 | ||
| Lactoferrin, an iron-binding protein in neutrophilic leukocytes | Q41842598 | ||
| Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techniques | Q42151128 | ||
| Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease | Q43624453 | ||
| The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis | Q48090510 | ||
| Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients | Q48191627 | ||
| 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons | Q48265152 | ||
| The importance of inflammatory mechanisms in Alzheimer disease | Q48380991 | ||
| Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q48385796 | ||
| Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase | Q48681443 | ||
| Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease | Q56567926 | ||
| An iron-binding protein common to many external secretions | Q57098816 | ||
| Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment | Q64854159 | ||
| Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. | Q67403760 | ||
| Brain macrophages: evaluation of microglia and their functions | Q68222913 | ||
| Lactoferrin, C-reactive protein, alpha-1-antitrypsin and immunoglobulin GA in cerebrospinal fluid in meningitis | Q68804677 | ||
| Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography | Q69329836 | ||
| Production of tumor necrosis factor-alpha by microglia and astrocytes in culture | Q69693619 | ||
| Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases | Q71469541 | ||
| Antioxidant action of neuromelanin: the mechanism of inhibitory effect on lipid peroxidation | Q72289910 | ||
| Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation | Q72632686 | ||
| Tumor necrosis factor-alpha increases lactoferrin transcytosis through the blood-brain barrier | Q73229643 | ||
| [Preparation and properties of lactosiderophilin (lactotransferrin) of human milk] | Q79076068 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | substantia nigra | Q753278 |
| microglia | Q1622829 | ||
| P304 | page(s) | 103-113 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Molecular Brain Research | Q6895939 |
| P1476 | title | Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment | |
| P478 | volume | 96 |
| Q36797088 | Altered regulation of iron transport and storage in Parkinson's disease. |
| Q44620802 | Bovine lactoferrin has a nitric oxide-dependent hypotensive effect in rats |
| Q38796693 | Brain Iron Metabolism Dysfunction in Parkinson's Disease. |
| Q39721547 | Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line |
| Q37155141 | Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease |
| Q40492068 | Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer |
| Q36745818 | Immunomodulatory effects of lactoferrin |
| Q47708680 | Integrin alpha 10, CD44, PTEN, cadherin-11 and lactoferrin expressions are potential biomarkers for selecting patients in need of central nervous system prophylaxis in diffuse large B-cell lymphoma |
| Q50462329 | Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model |
| Q64076840 | Iron in Neurodegeneration - Cause or Consequence? |
| Q39085772 | Lactoferrin and prematurity: a promising milk protein? |
| Q44342186 | Lactoferrin elicits opioid-mediated antinociception without development of tolerance: central nNOS-1 set off duty? |
| Q44341191 | Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord |
| Q49324255 | New Progress on the Role of Glia in Iron Metabolism and Iron-Induced Degeneration of Dopamine Neurons in Parkinson's Disease |
| Q44318946 | Novel function of bovine milk-derived lactoferrin on antinociception mediated by mu-opioid receptor in the rat spinal cord |
| Q35673103 | The protective effect of lactoferrin on ventral mesencephalon neurons against MPP + is not connected with its iron binding ability |
Search more.